Cargando…
56. High Frequencies of Adverse Drug Events with Intravenous vs Oral High-Dose Trimethoprim-Sulfamethoxazole: An Opportunity for Antibiotic Stewardship
BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) is a high-bioavailability antibiotic associated with potentially serious adverse drug events (ADE). The objective of this study was to evaluate the safety of intravenous (IV) and oral (PO) high-dose TMP-SMX. METHODS: IRB-approved retrospective coho...
Autores principales: | Vuong, Lisa, Davis, Susan L, Jedinak, Tyler, Medler, Corey, Zofchak, Kristen, Veve, Michael P, Kenney, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644844/ http://dx.doi.org/10.1093/ofid/ofab466.258 |
Ejemplares similares
-
Sulfamethoxazole-Trimethoprim and Hyperkalemia in an Infant
por: Hudzik, Samantha A., et al.
Publicado: (2020) -
Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei
por: Dance, D.A.B., et al.
Publicado: (2014) -
Myocarditis after Trimethoprim/Sulfamethoxazole Treatment for Ehrlichiosis
por: Nayak, Seema U., et al.
Publicado: (2013) -
Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients
por: Majoni, Sandawana William, et al.
Publicado: (2017) -
Life-Threatening Thrombocytopenia Secondary to Trimethoprim/Sulfamethoxazole
por: Gaudel, Pramod, et al.
Publicado: (2017)